Immunotherapy is an essential option for current disease treatment. However, most patients fail to respond adequately to existing immunotherapies, such...

Speaker Dr. Manhee Suh, Co-founder & CTO, KACTUS What's Inside When dealing with solid tumors lacking specific biomarkers, the effectiveness...

Overview By leveraging its sophisticated ‘Structure Aided Design and Multiplex Screening (SAMS™)’ platform, along with extensive experience in process development...

Overview AccuBase™ is a new generation base editing tool independently developed by Base Therapeutics with exclusive global IP rights. AccuBase™ enzyme is...

On November 13, 2023, Legend Biotech officially announced that its wholly-owned subsidiary, Legend Biotech Ireland Limited, has entered into an...

KACTUS and Base Therapeutics announced their new strategic partnership to facilitate global manufacturing and sales of the GMP-grade base editor...

ManHee Suh's Talk @ CAR-TCR Summit We are delighted to share with you our experience at the 8th CAR-TCR Summit...

Every year, on August 18th, the world comes together to observe World Breast Cancer Research Day—a day dedicated to raising...

On April 3, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced the completion of the rolling biologics license application (BLAs) to...

MICA, also known as MHC Class I Polypeptide-Related Sequence A, is a type I MHC molecule that is highly homologous...

Organoids are a three-dimensional model established in vitro that is highly similar to tissues or organs in vivo, and can...

At the ASCO annual meeting in 2023, Boehringer-Ingelheim disclosed the phase I clinical data of their bispecific antibody drug BI...